Published in Med Care on April 01, 1991
Health status of Medicare enrollees in HMOs and fee-for-service in 1994. Health Care Financ Rev (1996) 3.10
Understanding biased selection in Medicare HMOs. Health Serv Res (2003) 2.83
Selection experiences in Medicare HMOs: pre-enrollment expenditures. Health Care Financ Rev (1999) 1.64
Measuring coding intensity in the Medicare Advantage program. Medicare Medicaid Res Rev (2014) 1.10
Medigap premiums and Medicare HMO enrollment. Health Serv Res (2002) 1.02
Patient selection in the ESRD managed care demonstration. Health Care Financ Rev (2003) 0.91
Effects of the relative fee structure on the use of surgical operations. Health Serv Res (1993) 0.77
The concept of access: definition and relationship to consumer satisfaction. Med Care (1981) 10.22
Increasing Medicare enrollment in HMOs: the need for capitation rates adjusted for health status. Inquiry (1983) 3.21
Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet (1999) 3.15
Functional health measure for adjusting health maintenance organization capitation rates. Health Care Financ Rev (1986) 2.63
NHLBI plans for the promise of cell-based therapies. Cytotherapy (2005) 2.04
Characteristics of adolescents' sexual partners and their association with use of condoms and other contraceptive methods. Fam Plann Perspect (2001) 2.01
Including health status in Medicare's Adjusted Average Per Capita Cost capitation formula. Med Care (1986) 1.88
Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families. J Immunol (1989) 1.88
Immune response gene control of determinant selection. III. Polypeptide fragments of insulin are differentially recognized by T but not by B cells in insulin immune guinea pigs. J Immunol (1981) 1.71
Possible proton relay pathways in cytochrome c oxidase. Proc Natl Acad Sci U S A (1995) 1.62
GABAergic modulation of benzodiazepine binding site sensitivity. Nature (1978) 1.58
Insight into the active-site structure and function of cytochrome oxidase by analysis of site-directed mutants of bacterial cytochrome aa3 and cytochrome bo. J Bioenerg Biomembr (1993) 1.49
B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J Immunol (2001) 1.45
Assessment of weighting methodology for the National Comorbidity Survey. Am J Epidemiol (1997) 1.34
The cytochrome oxidase superfamily of redox-driven proton pumps. Trends Biochem Sci (1994) 1.28
Relating satisfaction with access to utilization of services. Med Care (1984) 1.24
Medical students' knowledge and misconceptions about aging: responses to Palmore's Facts on Aging Quizzes. Gerontologist (1992) 1.17
Anergy and not clonal ignorance determines the fate of B cells that recognize a physiological autoantigen. J Immunol (2001) 1.16
Autoimmune pancreatitis results from loss of TGFbeta signalling in S100A4-positive dendritic cells. Gut (2009) 1.16
Chromosome-wide linkage disequilibrium caused by an inversion polymorphism in the white-throated sparrow (Zonotrichia albicollis). Heredity (Edinb) (2010) 1.14
Clinical and sociodemographic risk factors for readmission of Medicare beneficiaries. Health Care Financ Rev (1988) 1.14
In vitro lymphocyte responses and skin test reactivity following BCG vaccination. Clin Exp Immunol (1971) 1.13
Defining hospital clusters and associated service communities in metropolitan areas. Socioecon Plann Sci (1981) 1.09
Benefits derived from routine testing for milk ketones. J Dairy Sci (1968) 1.09
Computational and experimental analyses reveal previously undetected coding exons of the KRIT1 (CCM1) gene. Genomics (2001) 1.08
A study of the two-filter method for radon-222. Health Phys (1970) 1.06
Lymphocyte transformation by phytohemagglutinin. I. In Hodgkin's Disease. Can Med Assoc J (1967) 1.05
H-2-linked Ir gene control of antibody responses to insulin. I. Anti-insulin plaque-forming cell primary responses. J Immunol (1979) 1.05
Including a measure of health status in Medicare's health maintenance organization capitation formula: reliability issues. Med Care (1987) 1.03
Lymphocyte transformation by phytohemagglutinin. II. In the tuberculous patient. Can Med Assoc J (1967) 1.03
Determination of the ligands of the low spin heme of the cytochrome o ubiquinol oxidase complex using site-directed mutagenesis. J Biol Chem (1992) 1.01
Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects. JAMA (1986) 1.00
Guide-wire entrapment by inferior vena caval filters: in vitro evaluation. Radiology (1996) 0.99
Structural requirements for the specific recognition of an m7G mRNA cap. Biochemistry (2000) 0.99
Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus. J Immunol (1989) 0.99
Techniques for defining geographic boundaries for health regions. Socioecon Plann Sci (1979) 0.98
The low-spin heme site of cytochrome o from Escherichia coli is promiscuous with respect to heme type. Biochemistry (1992) 0.97
Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM. Diabetes (1990) 0.97
Isolation of a human brain cDNA for glutamate dehydrogenase. J Neurochem (1987) 0.96
Statistical comparison of residential soil concentrations of PCDDs, PCDFs, and PCBs from two communities in Michigan. Environ Sci Technol (2008) 0.96
Retinal hemangioblastoma. A histologic, immunohistochemical, and ultrastructural evaluation. Ophthalmology (1992) 0.95
Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects. N Engl J Med (1983) 0.95
Characterization of photoaffinity labeling of benzodiazepine binding sites. J Biol Chem (1981) 0.94
Effect of therapeutic irradiation on lymphocyte transformation in lung cancer. Cancer (1971) 0.94
Antigen processing and the human T cell receptor repertoire for insulin. J Immunol (1988) 0.93
"Lumps" and "bumps" that mimic acute aortic and brachiocephalic vessel injury. Radiographics (1997) 0.92
Measurement of radon daughters in air. Health Phys (1972) 0.91
VH and VL gene usage by murine IgG antibodies that bind autologous insulin. J Immunol (1990) 0.91
Impact of nutrition education and mega-dose vitamin A supplementation on the health of children in Nepal. Bull World Health Organ (1996) 0.90
Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells. J Immunol (1999) 0.90
ComboScreen facilitates the multiplex hybridization-based screening of high-density clone arrays. Bioinformatics (2000) 0.90
A comparison of self-reported measures of perceived health and functional health in an elderly population. J Community Health (1987) 0.89
Isolation of a cDNA for rat brain glutaminase. Brain Res (1988) 0.89
Kinetics of electron and proton transfer during the reaction of wild type and helix VI mutants of cytochrome bo3 with oxygen. Biochemistry (1996) 0.89
Activation by autophosphorylation or cGMP binding produces a similar apparent conformational change in cGMP-dependent protein kinase. J Biol Chem (1998) 0.88
Glutamate-89 in subunit II of cytochrome bo3 from Escherichia coli is required for the function of the heme-copper oxidase. Biochemistry (1999) 0.88
Identity of the axial ligand of the high-spin heme in cytochrome oxidase: spectroscopic characterization of mutants in the bo-type oxidase of Escherichia coli and the aa3-type oxidase of Rhodobacter sphaeroides. Biochemistry (1993) 0.88
The effects of gastric exclusion operations on pancreatic exocrine secretion. Surgery (1974) 0.87
HMO marketing and selection bias: are TEFRA HMOs skimming? Med Care (1992) 0.87
Dexamethasone regulates glutamine synthetase expression in rat skeletal muscles. Am J Physiol (1988) 0.87
Frequency and specificity of protamine antibodies in diabetic and control subjects. Diabetes (1988) 0.87
Detecting and preventing adverse drug interactions: the potential contribution of computers in pharmacies. Soc Sci Med (1986) 0.86
Effects of dietary amines on the small intestine in calves fed soybean protein. J Nutr (1989) 0.86
Physical localization of eed: a region of mouse chromosome 7 required for gastrulation. Genomics (1995) 0.85
Comparative physical mapping of targeted regions of the rat genome. Mamm Genome (2001) 0.85
A structural basis for human cross-reacting idiotypes. Ann Inst Pasteur Immunol (1989) 0.85
X-ray diffraction studies on metal deposition in group D streptococci. J Bacteriol (1966) 0.85
Insulin-specific human T cells. Epitope specificity, major histocompatibility complex restriction, and alloreactivity to a diabetes-associated haplotype. J Immunol (1987) 0.85
Lymphocyte transformation by phytohemagglutinin: IV. In acute upper respiratory infections. Can Med Assoc J (1968) 0.84
The human immune response to insulin. I. Kinetic and cellular aspects of lymphocyte proliferative responses in diabetics. J Immunol (1983) 0.84
Factors influencing readmission risk: implications for quality monitoring. Health Care Financ Rev (1989) 0.84
Solubilization of benzodiazepine binding site from rat cortex. Life Sci (1979) 0.84
Dissemination of an innovative technical therapy through an evaluated practical workshop using live patient simulators. J Med Educ (1981) 0.84
Failure of antilymphocytic globulin therapy in chronic progressive multiple sclerosis. Neurology (1973) 0.84
Factors affecting the insulin autoantibody ELISA. Autoimmunity (1989) 0.84
Characterization of a [3H]glycine recognition site as a modulatory site of the N-methyl-D-aspartate receptor complex. J Neurochem (1989) 0.83
Spectroscopic characterization of mutants supports the assignment of histidine-419 as the axial ligand of heme o in the binuclear center of the cytochrome bo ubiquinol oxidase from Escherichia coli. Biochemistry (1993) 0.83
Flash photolysis of the carbon monoxide compounds of wild-type and mutant variants of cytochrome bo from Escherichia coli. Biochim Biophys Acta (1994) 0.83
In vitro growth of basophils containing the Philadelphia chromosome in the acute phase of chronic myelogenous leukaemia. Br J Haematol (1978) 0.83
Epitope analysis of insulin autoantibodies using recombinant Fab. Clin Exp Immunol (2005) 0.82
GABA-benzodiazepine interactions: physiological, pharmacological and developmental aspects. Fed Proc (1980) 0.82
Meadow vole nutrition studies with semisynthetic diets. J Nutr (1970) 0.82
Idiotypic determinants on human anti-insulin antibodies are cyclically expressed. J Immunol (1986) 0.82
Glucocorticoid receptor-mediated induction of glutamine synthetase in skeletal muscle cells in vitro. Endocrinology (1987) 0.81
Observations in immunotherapy of lymphoma and melanoma patients. Clin Exp Immunol (1975) 0.81
Autoreactive T cells from a type I diabetic recognize multiple class II products. Hum Immunol (1993) 0.81
Human exposure from dioxins in soil. Environ Sci Technol (2011) 0.81
CD11b+CD28-CD4+ human T cells: activation requirements and association with HLA-DR alleles. J Immunol (1996) 0.81
Effect of GABAergic drugs on benzodiazepine binding site sensitivity in rat cerebral cortex. Biochem Pharmacol (1978) 0.81
Insulin-specific tolerance induction. I. Abrogation of helper T cell activity is controlled by H-2-linked Ir genes. J Immunol (1984) 0.81
Use of combinatorial mutagenesis to select for multiply substituted human interleukin-3 variants with improved pharmacologic properties. Exp Hematol (1999) 0.80
Effects of previous calcium intakes on adaptation to low and high calcium diets in rats. J Nutr (1969) 0.80
Hemodialysis central venous catheter tip fracture with embolization into the pulmonary artery. Am J Kidney Dis (2001) 0.80
A loop between transmembrane helices IX and X of subunit I of cytochrome c oxidase caps the heme a-heme a3-CuB center. Biochemistry (1994) 0.80
Lymphocyte transformation by phytohemagglutinin. 3. In vitro cytotoxicity. Can Med Assoc J (1968) 0.80
Human insulin autoantibody fine specificity and H and L chain use. J Immunol (1989) 0.80